Phoenix PharmaLabs Co-Founder to speak at Upcoming College on Problems of Drug Dependence (CPDD) 80th Annual Meeting in San Diego
Lawrence Toll, Ph.D., expected to describe company’s novel opioid that shows no signs of addiction potential May 24, 2018 07:00
Read more